Shares of Supernus Pharmaceuticals Inc. more than doubled in price Tuesday after the specialty drugmaker said regulators have moved closer to granting final approval to its potential epilepsy treatment ...

Read the original article
Brought to you by Yahoo! News

Return to Epilepsy News